By Cátia Bandeiras, PhD Student at University of Lisbon, Portugal and Massachusetts Institute of Technology. See tweets from the conference using #ISSCR2017 @apulgarita I just wrapped up my stay at the Annual Meeting of ISSCR 2017, which happened in Boston. I decided to take advantage of the fact that I am living in Boston at […]
Hunting for computational approaches for stem cells at ISSCR2017 Read More »
Ring the bell for a stem cell milestone, specifically for iPS cell work. There’s been a whole lot of commotion about the NEJM article yesterday documenting the experiences of three women with macular degeneration who were blinded by non-FDA approved stem cell eye injections of fat stem cells at a business in Florida, but in the
Takahashi team IPS cell vision paper marks major stem cell milestone Read More »
A new Cell paper from Juan Carlos Izpisua Berlmonte’s group has made headlines about anti-aging across the globe because it suggests that the four core induced pluripotent stem cell (IPSC) factors use by Shinya Yamanaka to make IPSC can reverse aging. I’ve pasted the graphical abstract from the paper below and done a quick journal club style
Quick journal club on IPSC anti-aging paper: cool, but outstanding questions Read More »
By Samantha Yammine, PhD Candidate in Derek van der Kooy’s lab at the University of Toronto. See tweets live from #TMM2016 via @SamanthaZY here. Last week, 430 Canadian scientists, trainees, industry professionals, science communicators and international guests gathered in the picturesque ski town of Whistler, British Columbia for the annual Till & McCulloch meeting (TMM).
In the past year there has been a great deal of attention given to the potential use of CRISPR-Cas9 for gene editing in human embryos. An important recent development, described in a new NPR article by Rob Stein, is the use of CRISPR-Cas9 in healthy human embryos for developmental biology research by assistant professor Fredrik
Interview with Fredrik Lanner who is CRISPR’ing healthy human embryos Read More »
Some good news today as the pioneering induced pluripotent stem (IPS) cell trial led by Dr. Masayo Takahashi will resume. This clinical study with a focus on macular degeneration has been on hold for quite some time due to regulatory changes in Japan. There had also been concerns over mutations in the 2nd patient’s IPS
Good stem cell news as Masayo Takahashi IPS Cell Trial to Resume Read More »
There’s some big, positive news on the stem cell front today. Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of small molecules was able to turn them directly into
Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »
The patent dispute on CRISPR between UC/Jennifer Doudna and The Broad/Feng Zhang has been the subject of major attention including in a recent piece on Stanford Center for Law & Biosciences Blog. There is a lot of confusion over this important CRISPR dispute so I turned to a patent expert for their take on this via an interview
Patent expert weighs in on CRISPR dispute between UC & Broad Read More »
Just how often do press releases (PR) get science wrong? A new paper came out from the lab of Matthias Lutolf in Nature Materials that seems interesting. Using a special matrix, reprogramming of cells reportedly worked better. Good stuff. However, a (PR) from the home institution of EPFL and media pick up on the story used
Squeeze PR on stem cell paper evokes STAP cell bad vibrations, gets corrected Read More »
It’s time for The Niche 4th annual Stem Cell Person of the Year Award process to start. Please send me your nominations for the person you think had the biggest positive impact in the stem cell and regenerative medicine world in 2015. This award is unique in a number of ways. For example, anyone in
Stem Cell Person of the Year Award 2015: Nominations Open Read More »